Data protection Impressum

Financing

Geneva-based Sparta has secured USD 42 million in Series B funding, reinforcing its role as a market leader in AI-driven commodity trading intelligence.

Sparta raises USD 42 million to expand AI-powered commodity trading

25 February 2025

Vaud-based biopharma Oculis has successfully completed an oversubscribed USD 100 million offering, further strengthening its pipeline of innovative ophthalmic and neuro-ophthalmic treatments.

Oculis secures USD 100 million to advance its neuroprotective treatment pipeline

17 February 2025

The Deep Tech Nation Switzerland Foundation and the Startupticker Foundation have launched the Deep Tech Nation Information Platform, a central resource aimed at enhancing venture capital investment in Swiss deep tech start-ups.

Launch of the Swiss Deep Tech Information Platform

10 February 2025

The Foundation for Innovation and Technology has awarded Tech Grants to five promising projects from CHUV, EPFL, and HEIG-VD. The grants will support innovations in medical technology, robotics, and sustainable agriculture.

FIT awards Tech Grants to five cutting-edge projects from CHUV, EPFL and HEIG-VD

5 February 2025

Vaud-based AI company Largo.ai has raised CHF 7 million in a Series A round to accelerate its AI-driven solutions for film, TV, and advertising. Hollywood icon Sylvester Stallone joins as a strategic investor, marking a major step in the company’s expansion.

Largo.ai secures CHF 7 million to expand AI-driven film solutions

5 February 2025

Swiss start-ups raised CHF 2.4 billion in venture capital in 2024, marking an 8.5% decline from the previous year. The number of financing rounds also fell for the first time, reflecting a challenging investment climate. Despite these setbacks, biotech and cleantech sectors saw strong growth, and investor sentiment remains optimistic for 2025.

Business environment

Swiss start-ups secure CHF 2.4 billion in 2024 amid shifting investment trends

4 February 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (January 2025)

28 January 2025

Geneva-based Transmutex has been awarded USD 4.2 million from the U.S. Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) as part of the NEWTON program. The funding will support a project at Los Alamos to develop technologies that transform long-lived radioactive waste into shorter-lived isotopes, addressing a critical challenge in nuclear waste management.

Transmutex secures USD 4.2 million for the transmutation of nuclear waste

27 January 2025

EPFL Innovation Park biotech company AB2 Bio has signed an option and licensing agreement with Japan-based Nippon Shinyaku to advance Tadekinig alfa, a novel treatment for Primary Monogenic IL-18 driven Hyperinflammatory Syndrome. The deal includes up to USD 36 million in early payments and milestone-based funding of up to USD 650 million.

AB2 Bio secures USD 650 million partnership with Nippon Shinyaku for rare disease therapy

27 January 2025

EBAMed has secured an additional EUR 1.6 million in Series A funding, bringing the total raised to EUR 16 million. This new investment, contributed by CDP Venture Capital and the European Union, supports the development of EBAMed’s groundbreaking CardioKit system for non-invasive treatment of heart arrhythmias using Proton Therapy.

Geneva medtech EBAMed completes financing round with EUR 16 million

27 January 2025

1 2 3 4 5 6 7 8 9 … 33